FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine and pharmaceutics, namely to medication for treatment or prevention of cardiovascular system and/or nervous system diseases. Medication contains ethylmethylhydroxypyridine succinate, pyridoxine hydrochloride, pharmaceutically acceptable salt of magnesium and auxiliary substances in quantities given in invention formula. Method of cardiovascular and/or nervous system diseases treatment includes peroral introduction of medication by invention in efficient quantity. Also described is method of obtaining claimed medication.
EFFECT: obtaining highly technological medication characterised by low cost and high therapeutic effect.
13 cl, 6 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTIONS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE AND PYRIDOXIN, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2008 |
|
RU2383331C1 |
BIOLOGICALLY ACTIVE ADDITIVE FOR PREVENTION AND TREATMENT OF VEGETATIVE-VASCULAR DYSTONIA AND WAY OF ITS RECEPTION | 2008 |
|
RU2361602C1 |
METHOD OF TREATING NON-ALCOHOLIC LIVER DISEASE ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2538221C1 |
HEPATOPROTECTOR FOR TREATING NON-ALCOHOLIC LIVER DISEASE IN TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2537227C1 |
METHOD FOR TREATING CHRONIC HEART FAILURE | 2005 |
|
RU2304964C2 |
METHOD OF PREVENTING THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2796891C1 |
PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
ANTIOXIDANT PREPARATION FOR TREATING AND PREVENTING NEUROLOGICAL PATHOLOGIES IN ANIMALS | 2023 |
|
RU2813928C1 |
METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE AND CHRONIC BRAIN ISCHEMIA | 2021 |
|
RU2752065C1 |
AGENT "ANGIOTONIK" AND METHOD FOR SUPPORTING THERAPY IN DISEASES OF CARDIOVASCULAR SYSTEM | 2005 |
|
RU2292901C2 |
Authors
Dates
2010-12-10—Published
2008-03-24—Filed